Magnus Financial Group LLC Abb Vie Inc. Transaction History

Magnus Financial Group LLC

$1.01 Billion
Q4 2024

A detailed history of Magnus Financial Group LLC transactions in Abb Vie Inc. stock. As of the latest transaction made, Magnus Financial Group LLC holds 6,477 shares of ABBV stock, worth $1.25 Million. This represents 0.11% of its overall portfolio holdings.

Number of Shares

6,477

Previous 8,978 27.86%

Holding current value

$1.25 Million

Previous $1.77 Million 35.1%

% of portfolio

0.11%

Previous 0.18%

25 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Jan 17, 2025	SELL	$164.99 - $203.87 $412,639 - $509,878	-2,501 Reduced 27.86%	6,477 $1.15 Million
Q3 2024 Oct 15, 2024	BUY	$163.84 - $199.33 $135,823 - $165,244	829 Added 10.17%	8,978 $1.77 Million
Q2 2024 Aug 01, 2024	SELL	$154.79 - $180.76 $29,719 - $34,705	-192 Reduced 2.3%	8,149 $1.4 Million
Q1 2024 May 03, 2024	BUY	$159.82 - $182.1 $142,239 - $162,069	890 Added 11.94%	8,341 $1.52 Million
Q4 2023 Feb 05, 2024	BUY	$137.6 - $154.97 $108,016 - $121,651	785 Added 11.78%	7,451 $1.15 Million
Q3 2023 Oct 10, 2023	BUY	$133.59 - $154.65 $4,942 - $5,722	37 Added 0.56%	6,666 $993,000
Q2 2023 Jul 19, 2023	BUY	$132.51 - $164.9 $5,962 - $7,420	45 Added 0.68%	6,629 $893,000
Q1 2023 May 10, 2023	BUY	$144.61 - $166.54 $33,404 - $38,470	231 Added 3.64%	6,584 $1.05 Million
Q4 2022 Feb 02, 2023	BUY	$138.31 - $165.87 $23,512 - $28,197	170 Added 2.75%	6,353 $1.03 Million
Q3 2022 Nov 09, 2022	BUY	$134.21 - $153.93 $48,047 - $55,106	358 Added 6.15%	6,183 $830,000
Q2 2022 Aug 11, 2022	BUY	$137.62 - $174.96 $16,239 - $20,645	118 Added 2.07%	5,825 $892,000
Q1 2022 May 12, 2022	BUY	$131.98 - $163.75 $37,482 - $46,505	284 Added 5.24%	5,707 $925,000
Q4 2021 Feb 10, 2022	BUY	$107.43 - $135.93 $43,938 - $55,595	409 Added 8.16%	5,423 $734,000
Q3 2021 Nov 12, 2021	BUY	$106.4 - $120.78 $4,468 - $5,072	42 Added 0.84%	5,014 $541,000
Q2 2021 Aug 06, 2021	BUY	$105.21 - $117.21 $29,564 - $32,936	281 Added 5.99%	4,972 $560,000
Q1 2021 May 05, 2021	SELL	$102.3 - $112.62 $470,682 - $518,164	-4,601 Reduced 49.52%	4,691 $508,000
Q4 2020 Feb 05, 2021	SELL	$80.49 - $108.67 $61,333 - $82,806	-762 Reduced 7.58%	9,292 $996,000
Q3 2020 Nov 05, 2020	SELL	$85.91 - $100.83 $434,704 - $510,199	-5,060 Reduced 33.48%	10,054 $881,000
Q2 2020 Aug 11, 2020	SELL	$73.37 - $98.18 $8,510 - $11,388	-116 Reduced 0.76%	15,114 $1.48 Million
Q1 2020 May 11, 2020	BUY	$64.5 - $97.79 $677,379 - $1.03 Million	10,502 Added 222.12%	15,230 $1.16 Million
Q4 2019 Jan 28, 2020	BUY	$72.13 - $90.25 $5,409 - $6,768	75 Added 1.61%	4,728 $419,000
Q3 2019 Nov 08, 2019	BUY	$62.98 - $75.72 $53,910 - $64,816	856 Added 22.54%	4,653 $352,000
Q2 2019 Aug 05, 2019	BUY	$65.7 - $83.98 $2,299 - $2,939	35 Added 0.93%	3,797 $276,000
Q1 2019 May 09, 2019	SELL	$77.14 - $90.79 $88,942 - $104,680	-1,153 Reduced 23.46%	3,762 $303,000
Q4 2018 Feb 13, 2019	BUY	$77.85 - $96.01 $382,632 - $471,889	4,915 New	4,915 $453,000

Others Institutions Holding ABBV

# of Institutions

4,078

Shares Held

1.28B

Call Options Held

16.9M

Put Options Held

15.1M

View Full List

About AbbVie Inc.

Ticker ABBV
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,768,099,968
Market Cap $341B
Description
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...

More about ABBV

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Magnus Financial Group LLC, based on Form 13F filings with the SEC.

News

Stay updated on Magnus Financial Group LLC with notifications on news.

Account

Magnus Financial Group LLC Abb Vie Inc. Transaction History